ATMIN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.835800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.795200E-01
Normal-vs-Stage2
7.383200E-01
Normal-vs-Stage3
4.986300E-02
Normal-vs-Stage4
4.035400E-01
Stage1-vs-Stage2
7.421600E-01
Stage1-vs-Stage3
5.311600E-02
Stage1-vs-Stage4
2.484000E-01
Stage2-vs-Stage3
1.847770E-01
Stage2-vs-Stage4
1.452440E-01
Stage3-vs-Stage4
4.174000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.768200E-01
Normal-vs-AfricanAmerican
7.800000E-01
Normal-vs-Asian
1.806990E-01
Caucasian-vs-AfricanAmerican
4.282200E-01
Caucasian-vs-Asian
1.030240E-01
AfricanAmerican-vs-Asian
6.610200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.566200E-01
Normal-vs-Female
8.284000E-01
Male-vs-Female
6.296200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.218800E-01
Normal-vs-Age(41-60Yrs)
7.279800E-01
Normal-vs-Age(61-80Yrs)
5.830600E-01
Normal-vs-Age(81-100Yrs)
6.090800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.389200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.619600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.068800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.939490E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.107560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.918600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.131400E-01
Normal-vs-Daily Drinker
4.347200E-01
Normal-vs-Weekly Drinker
6.088600E-01
Normal-vs-Occasional Drinker
5.580200E-01
Normal-vs-Social Drinker
9.852000E-01
Non Drinker-vs-Daily Drinker
9.203200E-01
Non Drinker-vs-Weekly Drinker
5.478000E-01
Non Drinker-vs-Occasional Drinker
2.575900E-03
Non Drinker-vs-Social Drinker
9.658000E-02
Daily Drinker-vs-Weekly Drinker
6.667800E-01
Daily Drinker-vs-Occasional Drinker
1.337910E-02
Daily Drinker-vs-Social Drinker
1.825030E-01
Weekly Drinker-vs-Occasional Drinker
7.055900E-02
Weekly Drinker-vs-Social Drinker
4.179800E-01
Occasional Drinker-vs-Social Drinker
4.032800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.276570E-01
Normal-vs-Grade 2
3.394000E-02
Normal-vs-Grade 3
2.474100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.844250E-01
Grade 1-vs-Grade 3
3.635700E-02
Grade 1-vs-Grade 4
1.276570E-01
Grade 2-vs-Grade 3
1.822170E-01
Grade 2-vs-Grade 4
3.394000E-02
Grade 3-vs-Grade 4
2.474100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.642600E-01
Normal-vs-NonDiabetic
6.808800E-01
Diabetic-vs-NonDiabetic
8.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.854800E-01
Normal-vs-NoPancreatitis
7.324000E-01
Pancreatitis-vs-NoPancreatitis
5.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.844200E-01
Normal-vs-N1
8.010400E-01
N0-vs-N1
9.332000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.457200E-01
Normal-vs-TP53-NonMutant
9.764400E-01
TP53-Mutant-vs-TP53-NonMutant
4.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
